Novo Nordisk's problems keeping up US supply of Wegovy for weight-loss is back after a brief hiatus, as the company says starter doses will again be in short supply through September.
May 5, 2023 -- The on-again, off-again saga of Wegovy supply problems for U.S. patients looking to lose weight is back.
The update added that the bottleneck is caused by supply failing to meet U.S. demand, although the announcement also assured patients already using the drug and taking higher weekly dosages that their supply should not be affected. A shortage of doses for 0.25 mg, 0.5 mg, and 1 mg will mostly affect people starting on Wegovy. To avoid or minimize side effects, especially gastrointestinal effects, when patients start treatment with semaglutide or any other similar drug, they begin on the lowest dose and gradually work up to a maintenance dose, which for Wegovy can be up to 2.4 mg/week.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Novo Nordisk cuts some US supply of obesity drug Wegovy to cope with demandDanish drug developer Novo Nordisk said it would have to halve the supply of starter doses of its popular Wegovy weight-loss drug in the United States to cope with high demand after reporting forecast-beating results on Thursday.
Les mer »
Wegovy US Supply Shortage Strikes AgainNovo Nordisk's problem with keeping up the US supply of semaglutide for weight loss (Wegovy) is back after a brief hiatus, as the company says starter doses will again be in short supply through September.
Les mer »
Novo Nordisk limits distribution of low doses of Wegovy in U.S.Novo Nordisk is holding back low doses of Wegovy, its recently approved obesity medication, in the U.S. to conserve supplies for patients already using the drug, the company said Thursday.
Les mer »
Wegovy weight-loss drug supply to be temporarily curtailed by Novo Nordisk as it ramps up productionNovo Nordisk on Thursday said demand is so strong for its weight loss injectable medicine that it will have to reduce the supply temporarily.
Les mer »
Wegovy Maker to Limit Starter-Dose Supplies in U.S. as Demand SurgesLower-strength starter doses of the obesity drug will be held back in the U.S. to safeguard supplies, said pharmaceutical company Novo Nordisk.
Les mer »
Why You Might Not Be Able to Start Taking WegovyWhy You Might Not Be Able to Start Taking Wegovy The maker of the weight-loss version of Ozempic has limited starter-dose supplies in the U.S. to protect supplies for current users via WSJ
Les mer »